ISB News

Three Collaborative Projects Announced for ISB’s 2022 Innovator Award Program

2022 Innovator Awards

ISB kicked off the sixth year of our successful Innovator Award Program by announcing three collaborative projects. This internal program is designed to support novel research ideas that cut across disciplines and research groups. Washington Research Foundation once again generously pledged $100,000 to fund the awards. ISB also received an additional $50,000 matching donation from a generous donor.

WRF

2022 Innovator Awardees

2022 Innovators

The lead investigators of the 2022 Innovator Awardees, pictured left to right: Becky Howsmon, Program Manager, Systems Education Experiences (Baliga Lab); Christian Diener, Research Scientist (Gibbons Lab); Miranda Johnson, Systems Thinkers in STEM Coordinator, Systems Education Experiences (Baliga Lab).

This year’s projects and awardees are:

Title: Demystifying Machine Learning for the High School Classroom
Lead Investigator: Becky Howsmon, Program Manager, Systems Education Experiences
ISB Collaborators: Miranda Johnson, Sevda Molani, Chris Lausted, and Annie Levine

Title: A Clinical and Experimental Exploration of Gut Microbiome-Statin Interactions
Lead Investigator: Christian Diener, Research Scientist
ISB Collaborators: Sevda Molani, Qi Wei, Noa Rappaport, Tomasz Wilmanski, Karl Gaisser, and Evan Pepper
External Collaborator: Johanna Lampe, Research Professor, Fred Hutchinson Cancer Research Center

Title: Advancing the Next Generation of Leaders in Science
Lead Investigator: Miranda Johnson, Systems Thinkers in STEM Coordinator, Systems Education Experiences
ISB Collaborators: Eliza Peterson, Mόnica Orellana, Gabriela Verdezoto Mosquera, Ulrike Kusebauch, Sevda Molani, Yeon Mi Hwang, Becky Howsmon, Claudia Ludwig, and Charu Midha

Visit the Innovator Award Program landing page to learn more.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.